[
  {
    "ts": "2026-01-26T11:40:00+00:00",
    "headline": "3 Reasons to Buy This Dividend King After Its Steep Sell-Off",
    "summary": "Investors' reaction to this Dividend King's Q4 revenue miss was overdone.",
    "url": "https://www.fool.com/investing/2026/01/26/3-reasons-to-buy-this-dividend-king-after-its-stee/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "fa230b59-3c22-3bdf-ae71-59d301b4bda8",
      "content": {
        "id": "fa230b59-3c22-3bdf-ae71-59d301b4bda8",
        "contentType": "STORY",
        "title": "3 Reasons to Buy This Dividend King After Its Steep Sell-Off",
        "description": "",
        "summary": "Investors' reaction to this Dividend King's Q4 revenue miss was overdone.",
        "pubDate": "2026-01-26T11:40:00Z",
        "displayTime": "2026-01-26T11:40:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/6e388a4796b4739ff92674e6305730ff",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "A continuous blood glucose monitor device on a person's arm and a phone displaying a glucose reading chart.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SprBta.VqYPckpdOOinecw--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/6e388a4796b4739ff92674e6305730ff.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/i4MFlSuLHuKVIJCnPH2SMw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/6e388a4796b4739ff92674e6305730ff.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/01/26/3-reasons-to-buy-this-dividend-king-after-its-stee/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/3-reasons-buy-dividend-king-114000005.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-26T14:00:03+00:00",
    "headline": "Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
    "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-trending-stock-140003240.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "04ed4257-60d7-3ece-97ba-cf6cfd99fd82",
      "content": {
        "id": "04ed4257-60d7-3ece-97ba-cf6cfd99fd82",
        "contentType": "STORY",
        "title": "Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It",
        "description": "",
        "summary": "Zacks.com users have recently been watching Abbott (ABT) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.",
        "pubDate": "2026-01-26T14:00:03Z",
        "displayTime": "2026-01-26T14:00:03Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/39dfb058875b6e691de9136bc97a47b4",
          "originalWidth": 900,
          "originalHeight": 900,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/96m3P4v2KypZ_.2vXHQRKA--~B/aD05MDA7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/39dfb058875b6e691de9136bc97a47b4.cf.webp",
              "width": 900,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TvxSS8VO1p90iNVKrfS9eA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/39dfb058875b6e691de9136bc97a47b4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-trending-stock-140003240.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbott-laboratories-abt-trending-stock-140003240.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            },
            {
              "symbol": "^GSPC"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-26T10:06:04+00:00",
    "headline": "Intuitive’s cardiac initiative includes valve repair, LAA closure",
    "summary": "With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S. sites this year to establish cardiac programs.",
    "url": "https://www.medtechdive.com/news/intuitive-Surgical-robotic-cardiac-surgery-indications/810474/",
    "source": "MedTech Dive",
    "provider": "yfinance",
    "raw": {
      "id": "dfb4a4ba-3530-30b9-b1b2-235db08710ce",
      "content": {
        "id": "dfb4a4ba-3530-30b9-b1b2-235db08710ce",
        "contentType": "STORY",
        "title": "Intuitive’s cardiac initiative includes valve repair, LAA closure",
        "description": "",
        "summary": "With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S. sites this year to establish cardiac programs.",
        "pubDate": "2026-01-26T10:06:04Z",
        "displayTime": "2026-01-26T10:06:04Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/medtech_dive_335/e6969c6611b664be6927f165b20ef797",
          "originalWidth": 1600,
          "originalHeight": 900,
          "caption": "Clinicians have a discussion in front of a da Vinci 5 surgical robot at Florida's Tampa General Hospital.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/miL_KqM33uA3tPMj1CUmjA--~B/aD05MDA7dz0xNjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/medtech_dive_335/e6969c6611b664be6927f165b20ef797.cf.webp",
              "width": 1600,
              "height": 900,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OdKRkDFU1u8soUEJo5L9MA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/medtech_dive_335/e6969c6611b664be6927f165b20ef797.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "MedTech Dive",
          "url": "https://medtechdive.com/"
        },
        "canonicalUrl": {
          "url": "https://www.medtechdive.com/news/intuitive-Surgical-robotic-cardiac-surgery-indications/810474/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/intuitive-cardiac-initiative-includes-valve-100604256.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ISRG"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "ABT"
            },
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-01-26T21:43:25+00:00",
    "headline": "Evercore ISI Says Abbott’s (ABT) Core Growth Drivers Are Still Intact",
    "summary": "Abbott Laboratories (NYSE:ABT) is included among the 12 Most Profitable Dividend Stocks to Buy in 2026. On January 23, Evercore ISI trimmed its price target on Abbott Laboratories (NYSE:ABT) to $138 from $144. However, it kept an Outperform rating. The firm acknowledged the recent stumbles that led to a quarterly miss and a more cautious […]",
    "url": "https://finance.yahoo.com/news/evercore-isi-says-abbott-abt-214325952.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "0ba23cb7-533a-3e11-80df-1831cd7dcf5b",
      "content": {
        "id": "0ba23cb7-533a-3e11-80df-1831cd7dcf5b",
        "contentType": "STORY",
        "title": "Evercore ISI Says Abbott’s (ABT) Core Growth Drivers Are Still Intact",
        "description": "",
        "summary": "Abbott Laboratories (NYSE:ABT) is included among the 12 Most Profitable Dividend Stocks to Buy in 2026. On January 23, Evercore ISI trimmed its price target on Abbott Laboratories (NYSE:ABT) to $138 from $144. However, it kept an Outperform rating. The firm acknowledged the recent stumbles that led to a quarterly miss and a more cautious […]",
        "pubDate": "2026-01-26T21:43:25Z",
        "displayTime": "2026-01-26T21:43:25Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/3774069e75160f3491e217a8adc68902",
          "originalWidth": 580,
          "originalHeight": 387,
          "caption": "Evercore ISI Says Abbott’s (ABT) Core Growth Drivers Are Still Intact",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/t6RCH8PBlviwVdgmKACcLw--~B/aD0zODc7dz01ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/3774069e75160f3491e217a8adc68902.cf.webp",
              "width": 580,
              "height": 387,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/jo4VFE.womibB84sqffwDg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/3774069e75160f3491e217a8adc68902.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/evercore-isi-says-abbott-abt-214325952.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/evercore-isi-says-abbott-abt-214325952.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]